(Q34727085)

4 August 2017

1 reference

title

Interleukin-1beta converting enzyme (caspase-1) in intestinal inflammation (English)

1 reference

4 August 2017

0 references

Britta Siegmund

1

0 references

language of work or name

English

0 references

publication date

1 July 2002

1 reference

4 August 2017

published in

Biochemical Pharmacology

1 reference

4 August 2017

volume

64

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

1-8

1 reference

Inflammatory bowel disease: etiology and pathogenesis

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Antibodies to interleukin 12 abrogate established experimental colitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Human ICE/CED-3 protease nomenclature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Structure and mechanism of interleukin-1 beta converting enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Ligation of CD40 activates interleukin 1beta-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin 1beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Severity and mortality of experimental pancreatitis are dependent on interleukin-1 converting enzyme (ICE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Differential effects of caspase-1/interleukin-1beta-converting enzyme on acinar cell necrosis and apoptosis in severe acute experimental pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Therapeutic application of caspase 1/interleukin-1beta-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Shigella flexneri induces apoptosis in infected macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Role of interleukin-1 in the pathogenesis of experimental shigellosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Interleukin 1 is released by murine macrophages during apoptosis induced by Shigella flexneri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Relapsing amoebic colitis of 12 year's standing exacerbated by corticosteroids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Entamoeba histolytica cysteine proteinases with interleukin-1 beta converting enzyme (ICE) activity cause intestinal inflammation and tissue damage in amoebiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Molecular basis of the interaction of Salmonella with the intestinal mucosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Salmonella pathogenicity island 2-dependent macrophage death is mediated in part by the host cysteine protease caspase-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Salmonella exploits caspase-1 to colonize Peyer's patches in a murine typhoid model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Salmonella-induced macrophage death: the role of caspase-1 in death and inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

ICE/Caspase-1 inhibitors as novel anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Cloning of a new cytokine that induces IFN-gamma production by T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Coagulation of whole blood stimulates interleukin-1 beta gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Hyperosmotic stress as a stimulant for proinflammatory cytokine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Purification and characterization of the human interleukin-18 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Interleukin 1: the patterns of translation and intracellular distribution support alternative secretory mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Processing and activation of pro-interleukin-16 by caspase-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Multiple biological activities of human recombinant interleukin 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

IFN-gamma-dependent and -independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

In situ characterization of inflammatory responses in the rectal mucosae of patients with shigellosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901064-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(02)01064-X

1 reference

4 August 2017

1 reference